A Prospective Observational Study to Examine Patient Characteristics, Health Care Management, and Effectiveness Among HCV Patients Treated With Simeprevir at Various Practice Settings
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2016
At a glance
- Drugs Simeprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms SONET
- Sponsors Janssen
- 17 Apr 2016 Interim results (n=315) presented at The International Liver Congress™ 2016
- 11 Apr 2016 Data will be presented at The International Liver Congress 2016 of the European Association for the Study of the Liver (EASL), according to a Medivir AB media release.
- 19 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.